Stay updated on Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.

Latest updates to the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- A new revision entry, v3.6.3, is added to the history, replacing the previous v3.6.2. - This update reflects a change to the page's revision history rather than modifications to the study details or outcomes.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page. This reflects a software version update to the page rather than a change in study data.SummaryDifference0.0%

- Check29 days agoChange DetectedThe recruitment status is updated to indicate that the study is no longer recruiting participants. The record history also shows a new revision (v3.6.0) replacing the prior v3.5.5.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page history now includes a new revision entry v3.5.5, replacing v3.5.4—an update to the revision metadata rather than changes to study information.SummaryDifference0.0%

- Check57 days agoChange DetectedThe history now shows a new Revision: v3.5.4 entry, replacing the previous v3.5.3, indicating an update to the page's revision history.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page, indicating a small system update rather than changes to study records.SummaryDifference0.0%

Stay in the know with updates to Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.